Stock Analysis

Fufeng Group Full Year 2024 Earnings: In Line With Expectations

SEHK:546
Source: Shutterstock

Fufeng Group (HKG:546) Full Year 2024 Results

Key Financial Results

  • Revenue: CN¥27.8b (flat on FY 2023).
  • Net income: CN¥2.31b (down 27% from FY 2023).
  • Profit margin: 8.3% (down from 11% in FY 2023).
  • EPS: CN¥0.92 (down from CN¥1.24 in FY 2023).
revenue-and-expenses-breakdown
SEHK:546 Revenue and Expenses Breakdown March 31st 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Fufeng Group Meets Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations.

The primary driver behind last 12 months revenue was the Food Additives segment contributing a total revenue of CN¥14.4b (52% of total revenue). Notably, cost of sales worth CN¥22.7b amounted to 82% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Sales & Marketing costs, amounting to CN¥1.96b (72% of total expenses). Explore how 546's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 4.9% p.a. on average during the next 2 years, compared to a 6.8% growth forecast for the Chemicals industry in Hong Kong.

Performance of the Hong Kong Chemicals industry.

The company's shares are down 1.9% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 1 warning sign for Fufeng Group that you should be aware of.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SEHK:546

Fufeng Group

An investment holding company, engages in the manufacture and sale of fermentation-based food additive, and biochemical and starch-based products in the People’s Republic of China and internationally.

Undervalued with excellent balance sheet.